OK Biotech Co Ltd operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares OK Biotech Co Ltd with three other
pharmaceutical manufacturers in Asia:
Mizuho Medy Co Ltd
sales of 6.42 billion Japanese Yen [US$57.36 million]
of which 92%
was Hospital Business),
Kainos Laboratories, Inc.
(4.39 billion Japanese Yen [US$39.17 million]
BioSino Bio-technology and Science Inc
based in China
(303.22 million Chinese Renmimbi [US$45.20 million]
OK Biotech Co Ltd reported sales of 1.12 billion Taiwanese Dollars (US$36.29 million)
December of 2018.
decrease of 9.1%
versus 2017, when the company's sales were 1.23 billion Taiwanese Dollars.
The sales level in 2018 was fairly close to the level five years ago: in 2013, OK Biotech Co Ltd had sales
of 1.07 billion Taiwanese Dollars.